Research Solutions Inc (RSSS) reports significant ARR growth and improved margins, while addressing challenges in transaction revenue and customer retention.

TIC Solutions, Inc. (NYSE: TIC) ("TIC Solutions" or the "Company"), a leading provider of critical asset integrity solutions ...

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent corporate updates.

Microsoft's .NET 10 release highlights AI integration through the new Microsoft Agent Framework and related extensions, ...

Q3 2025 Earnings Call Transcript November 4, 2025 Exagen Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, ...

During the exhibition, BV will highlight its comprehensive solutions under the three key pillars of net-zero transformation — New Energy, Sustainability, and Cybersecurity — demonstrating BV's strong ...

Generated revenue of $35 million, driven by strong performance of the foundational PAC businessReported Adjusted EBITDA of $5.2 million, ...

Get key insights from Insight Molecular Diagnostics' Q3 2025 earnings call—FDA progress, $1B market outlook, and innovations in transplant testing.

Thank you, operator, and good afternoon, everyone. Thank you for joining us today for Research Solutions First Quarter Fiscal Year 2026 Earnings Call. On the call with me today are Roy W. Olivier, ...

Q3 2025 Earnings Call Transcript November 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Third Quarter Earnings Conference Call. [Operator ...

The upcoming NABL-accredited testing lab in Surat and our expanding portfolio of EHV (Extra High Voltage) services are strategic investments that will enhance our competitiveness, reduce external ...